Skip to main content
SpringerLink
Log in

Cardiomyopathy of glycogen storage disease type III

  • Originals
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Summary

To identify the severity of cardiac involvement in glycogen storage disease type III (GSDIII), and its relation to skeletal muscle involvement and age, 23 patients were studied. The median age was 10 years. Echocardiography, electrocardiography, and creatine phosphokinase (CK) levels were used to assess cardiac and skeletal muscle involvement. Septal and left ventricular posterior wall measurements were compared with normal data. Shortening fraction was derived from left ventricular cavity dimensions. In some patients the echocardiogram resembled that of hypertrophic cardiomyopathy. Thirteen of 20 electrocardiograms (ECG) were abnormal. Eleven patients had septal and/or posterior wall thickness >95% confidence limits (CL). Despite this, cardiac symptoms were uncommon. The CK levels were not directly associated with cardiac abnormalities. Older patients (>20 years) had more abnormal measurements of posterior wall thickness than did younger ones (<20 years). This finding, albeit in a cross-sectional series, suggests progressive myocardial involvement with age despite the absence of symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ehlers KH, Hagstrom JWC, Lukas DS, Redo SF, Engle MA (1962) Glycogen storage disease of the myocardium with obstruction to the left ventricular outflow. Circulation 25:96–109

    Google Scholar 

  2. Hohn AR, Lowe CU, Sokal JE, Lambert EC (1965) Cardiac problems in the glycogenoses, with specific reference to Pompe's disease. Pediatrics 35:313–321

    Google Scholar 

  3. Pernot C, Loth P, Gautier M (1978) Myocardiopathies des glycogenoses. Arch Mal Coeur 4:428–436

    Google Scholar 

  4. Rossignol AM, Meyer M, Rossignol B, Palcoux MP, Raynaud EJ, Bost M (1979) La myocardiopathie de la glycogenose type III. Arch Franc Pediat 36:303–309

    Google Scholar 

  5. Miller CG, Alleyne GA, Brooks AEH (1972) Gross cardiac involvement in glycogen storage disease type III. Br Heart J 34:862–864

    Google Scholar 

  6. Olson LJ, Reeder GS, Noller KL, Edwards WD, Howell RR, Michels VV (1984) Cardiac involvement in glycogen storage disease type III: Morphologic and biochemical characterization with endomyocardial biopsy. Am J Cardiol 53:980–981

    Google Scholar 

  7. Spencer-Peet J, Normal ME, Lake BD, McNamara J, Patrick AD (1971) Hepatic glycogen storage disease: Clinical and laboratory findings in 23 cases. Quart J Med 40:95–114

    Google Scholar 

  8. Henry WL, Gardin JM, Ware JH (1980) Echocardiographic measurements in normal subjects from infancy to old age. Circulation 62:1054–1060

    Google Scholar 

  9. Moses SW, Wandeman KL, Myroz A, Frydman M (1989) Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 148:764–766

    Google Scholar 

  10. Labrune P, Huguet P, Odievre M (1991) Cardiomyopathy in glycogen storage disease type III: Clinical and echographic study of 18 patients. Pediatr Cardiol 12:161–163

    Google Scholar 

  11. Brown BL, Brown DH (1968) Glycogen storage disease: Types I, III, IV, V, and VII and unclassified glycogenoses. In: Dickens F, Randle PJ, Whelan WJ (eds) Carbohydrate metabolism and its disorders. Academic, London, pp 123–150

    Google Scholar 

  12. DiMauro S, Hartwig GB, Hays A, Eastwood AB, Franco R, Olarte M, Chang M, Roses AD, Fetell M, Schoenfeldt RS, Stern LZ (1979) Debranch deficiency: Neuromuscular disorder in five adults. Ann Neurol 5:422–436

    Google Scholar 

  13. Slonin AE, Coleman Ra, Moses WS (1984) Myopathy and growth failure in debrancher enzyme deficiency: Improvement with high protein nocturnal therapy. J Pediatr 105:906–911

    Google Scholar 

  14. Shapiro LM, McKenna WJ (1983) Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A two-dimensional echocardiographic study. J Am Coll Cardiol 2:437–444

    Google Scholar 

  15. McKenna WJ, Deanfield JE (1984) Hypertrophic cardiomyopathy: An important cause of sudden death. Arch Dis Child 59:971–975

    Google Scholar 

  16. McKenna WJ, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J (1981) Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardio-graphic, and hemodynamic features. Am J Cardiol 47:532–538

    Google Scholar 

Download references

Author information

Author notes

  1. Julene S. Carvalho

    Present address: Department of Paediatric Cardiology, Royal Brompton National Heart and Lung Hospital, Sydney Street, SW3 6NP, London, United Kingdom

Authors and Affiliations

  1. Department of Paediatric Cardiology, Hospitals for Sick Children, Great Ormond Street, WC1N 3JH, London, UK

    Julene S. Carvalho & John Deanfield

  2. Institute of Child Health, 30 Guilford Street, WC1N 1EH, London, UK

    Eurem E. Matthews & James V. Leonard

Authors
  1. Julene S. Carvalho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eurem E. Matthews
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James V. Leonard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John Deanfield
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carvalho, J.S., Matthews, E.E., Leonard, J.V. et al. Cardiomyopathy of glycogen storage disease type III. Heart Vessels 8, 155–159 (1993). https://doi.org/10.1007/BF01744800

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01744800

Key words

Search

Navigation